Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir/Dasabuvir plus /- Ribavirin Regimen for Recurrent Genotype 1 HCV Infection After Liver Transplantation - Multicenter, Real-Life, AMBER-CEE Study

Ieva Tolmane; O. Tronina; M. Durlik; M. Wawrzynowicz-Syczewska; A. Buivydiene; Limas Kupčinskas; K. Katzarov; L. Kupcinskas; E. Karpinska; A. Pisula; K. Karwowska

Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir/Dasabuvir plus /- Ribavirin Regimen for Recurrent Genotype 1 HCV Infection After Liver Transplantation - Multicenter, Real-Life, AMBER-CEE Study

Ieva Tolmane
, O. Tronina
, M. Durlik
, M. Wawrzynowicz-Syczewska
, A. Buivydiene
, Limas Kupčinskas
, K. Katzarov
, L. Kupcinskas
, E. Karpinska
, A. Pisula
, K. Karwowska

Zinātniskās darbības rezultāts: Devums žurnālam › Konferences tēzes (žurnālā) › koleģiāli recenzēts

Oriģinālvaloda	Angļu
Žurnāls	Transplantation
Sējums	100
Publikācijas statuss	Publicēts - 2016
Pasākums	22nd Annual International Congress of the International Liver Transplantation Society - Seula, Dienvidkoreja Ilgums: 4 maijs 2016 → 7 maijs 2016

OECD Zinātnes nozare

3. Medicīnas un veselības zinātnes

Citēt šo

Tolmane, I., Tronina, O., Durlik, M., Wawrzynowicz-Syczewska, M., Buivydiene, A., Kupčinskas, L., Katzarov, K., Kupcinskas, L., Karpinska, E., Pisula, A., & Karwowska, K. (2016). Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir/Dasabuvir plus /- Ribavirin Regimen for Recurrent Genotype 1 HCV Infection After Liver Transplantation - Multicenter, Real-Life, AMBER-CEE Study. Transplantation, 100.

@article{08b84c83ce6c462dba78bb06999d7d07,

title = "Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir/Dasabuvir plus /- Ribavirin Regimen for Recurrent Genotype 1 HCV Infection After Liver Transplantation - Multicenter, Real-Life, AMBER-CEE Study",

author = "Ieva Tolmane and O. Tronina and M. Durlik and M. Wawrzynowicz-Syczewska and A. Buivydiene and Limas Kup{\v c}inskas and K. Katzarov and L. Kupcinskas and E. Karpinska and A. Pisula and K. Karwowska",

year = "2016",

language = "English",

volume = "100",

journal = "Transplantation",

issn = "0041-1337",

publisher = "Lippincott Williams and Wilkins",

note = "22nd Annual International Congress of the International Liver Transplantation Society, ILTS ; Conference date: 04-05-2016 Through 07-05-2016",

}

Tolmane, I, Tronina, O, Durlik, M, Wawrzynowicz-Syczewska, M, Buivydiene, A, Kupčinskas, L, Katzarov, K, Kupcinskas, L, Karpinska, E, Pisula, A & Karwowska, K 2016, 'Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir/Dasabuvir plus /- Ribavirin Regimen for Recurrent Genotype 1 HCV Infection After Liver Transplantation - Multicenter, Real-Life, AMBER-CEE Study', Transplantation, sēj. 100.

Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir/Dasabuvir plus /- Ribavirin Regimen for Recurrent Genotype 1 HCV Infection After Liver Transplantation - Multicenter, Real-Life, AMBER-CEE Study. / Tolmane, Ieva; Tronina, O.; Durlik, M. u.c.
(gadā): Transplantation, Sēj. 100, 2016.

Zinātniskās darbības rezultāts: Devums žurnālam › Konferences tēzes (žurnālā) › koleģiāli recenzēts

TY - JOUR

T1 - Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir/Dasabuvir plus /- Ribavirin Regimen for Recurrent Genotype 1 HCV Infection After Liver Transplantation - Multicenter, Real-Life, AMBER-CEE Study

AU - Tolmane, Ieva

AU - Tronina, O.

AU - Durlik, M.

AU - Wawrzynowicz-Syczewska, M.

AU - Buivydiene, A.

AU - Kupčinskas, Limas

AU - Katzarov, K.

AU - Kupcinskas, L.

AU - Karpinska, E.

AU - Pisula, A.

AU - Karwowska, K.

PY - 2016

Y1 - 2016

M3 - Meeting abstract

SN - 0041-1337

VL - 100

JO - Transplantation

JF - Transplantation

T2 - 22nd Annual International Congress of the International Liver Transplantation Society

Y2 - 4 May 2016 through 7 May 2016

ER -